One Year On: The Bioequivalence Guidelines
Hosted By : Helen WinsorJuly 20, 2011
About this Podcast...
Helmut Schuetz of BEBAC Consultancy and Anders Fuglsang of Fuglsang Pharma Consultancy, join Pharma IQ to discuss the impact of the bioequivalence guidelines introduced in summer 2010 on the pharmaceutical industry.
In this debate, we get the views of two key consultants within the field on how well the bioequivalence guidelines have been received, the main changes in the guidelines and how well aware of these the industry has been. They also discuss the problems experienced when it comes to implementing the guidelines and the elements they perceive to be missing which they would like to have seen included. Finally, Schuetz and Fuglsang reflect on how they predict the bioequivalence landscape to change over the next five year.
-
Cool Chain Logistics 2013
Congress Center Basel, Basel, Switzerland
January 28- 30, 2013 -
Global Pharmaceutical Distribution 2012
Venue to be Confirmed, Amsterdam, The Netherlands
September 18- 19, 2012 -
Information Governance & eDiscovery for Pharma, Biotech and Medical Devices
London, UK
June 26- 28, 2012 -
2nd Annual Pharma Regulatory Affairs Asia
Amara Singapore Hotel, Singapore
April 25- 26, 2012






Not a member? Sign Up
Reasons for Joining
Address your challenges through knowledge sharing with peers from our global network of specialists.
Benchmark your business initiatives with the who's who in the field.
Hear from industry pioneers how to maximize ROI in today's challenging economy.
And best of all It's FREE!